Hiv infection and HIV-associated behaviors among persons who inject drugs — 20 cities, united states, 2012

Morbidity and Mortality Weekly Report

Volumn 64, Issue 10, 2015, Pages 270-275

  Spiller, Michael W ^a   Broz, Dita ^a   Wejnert, Cyprian ^a   Nerlander, Lina ^a   Paz Bailey, Gabriela ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CAUCASIAN; CITY; ETHNOLOGY; FEMALE; HIGH RISK BEHAVIOR; HISPANIC; HIV INFECTIONS; HUMAN; MALE; MIDDLE AGED; PREVALENCE; PSYCHOLOGY; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CITIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK-TAKING; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; YOUNG ADULT;

EID: 84929045090     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. CDC. Diagnoses of HIV infection in the United States and dependent areas, 2012. HIV Surveillance Report, 2012. Vol. 24. Available at http:// www.cdc.gov/hiv/pdf/statistics_2012_HIV_Surveillance:Report_ vol_24.pdf.
2. Salganik MJ, Heckathorn DD. Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Method 2004;34:193–240.
3. CDC. HIV-associated behaviors among injecting-drug users—23 cities, United States, May 2005–February 2006. MMWR Morb Mortal Wkly Rep 2009;58:329–32.
4. CDC. HIV infection and HIV-associated behaviors among injecting drug users—20 cities, United States, 2009. MMWR Morb Mortal Wkly Rep 2012;61:133–8.
5. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005;39:446–53.
6. Salganik MJ. Variance estimation, design effects, and sample size calculations for respondent-driven sampling. J Urban Health 2006;83:i98–i112.
7. Tempalski B, Pouget ER, Cleland CM, et al. Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992– 2007. PLoS ONE 2013;8: e64789.
8. Broz D, Pham H, Spiller MW, et al. Prevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009. AIDS Behav 2014;18(Suppl 3):284–96.
9. CDC. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services. MMWR Recomm Rep 2012;61(No. RR-5).
10. CDC. Preexposure prophylaxis for the prevention of HIV infection in the United States—2014: a clinical practice guideline. Available at http://www.cdc.gov/hiv/pdf/guidelines/PrEPguidelines2014.pdf.